Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence

In 1987, Nigel Harris cautioned against over-diagnosing the antiphospholipid syndrome (APS). In what was a rather prophetic editorial titled 'The Syndrome of the Black Swan', he suggested that while patients with APS do indeed exist, they are probably much more unusual than many medical pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Human reproduction update 2012-09, Vol.18 (5), p.474-484
Hauptverfasser: Clark, Christine A, Laskin, Carl A, Spitzer, Karen A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 484
container_issue 5
container_start_page 474
container_title Human reproduction update
container_volume 18
creator Clark, Christine A
Laskin, Carl A
Spitzer, Karen A
description In 1987, Nigel Harris cautioned against over-diagnosing the antiphospholipid syndrome (APS). In what was a rather prophetic editorial titled 'The Syndrome of the Black Swan', he suggested that while patients with APS do indeed exist, they are probably much more unusual than many medical professionals might like to believe. He expressed concern that the value of studying antiphospholipid antibodies (aPLs) as interesting non-organ specific autoantibodies, would become lost in a 'sea of over-interpreted and over-reported laboratory and clinical findings'. It is our contention that 25 years later, this prediction has come to pass, particularly with respect to one type of aPL and its relation to a clinical event, namely anticardiolipin antibodies and early recurrent pregnancy loss. In this commentary, we trace the evolution of the current dogma and propose that reevaluation of available data from an alternative perspective results in quite a different understanding, the acceptance of which would necessitate not only a revision of the classification criteria for APS but also the subsequent revision of many diagnoses.
doi_str_mv 10.1093/humupd/dms020
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1030349006</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1030349006</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-5968dc6f918819abf7174611631042f8a696aac905b022692b0e63f7c272807e3</originalsourceid><addsrcrecordid>eNo9kE1PwzAMhiMEYjA4ckU5cilzkjZtuE0TX9IkLnClSlMXgvq1pJ3Uf0-mDk5-LT-y7IeQGwb3DJRYfY_N2JersvHA4YRcsFhCxIVUpyGLJIniNJMLcun9DwCTLEvPyYJzqRQwuCCf63awRrvSdrXtbUt16IuutOhDLKlDMzqH7UBRu3qivcOvVrdmonXn_QPV1ITh6CbaVRR3o913RtcU97bE1uAVOat07fH6WJfk4-nxffMSbd-eXzfrbWSE4EOUKJmVRlaKZRlTuqhSlsaSMSkYxLzKtFRSa6MgKeBwOy8ApahSw1OeQYpiSe7mvb3rdiP6IW-sN1jXusVu9DkDASJWADKg0YwaFz5wWOW9s412U4Dyg9J8VprPSgN_e1w9Fg2W__SfQ_ELcDd0Zg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1030349006</pqid></control><display><type>article</type><title>Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Clark, Christine A ; Laskin, Carl A ; Spitzer, Karen A</creator><creatorcontrib>Clark, Christine A ; Laskin, Carl A ; Spitzer, Karen A</creatorcontrib><description>In 1987, Nigel Harris cautioned against over-diagnosing the antiphospholipid syndrome (APS). In what was a rather prophetic editorial titled 'The Syndrome of the Black Swan', he suggested that while patients with APS do indeed exist, they are probably much more unusual than many medical professionals might like to believe. He expressed concern that the value of studying antiphospholipid antibodies (aPLs) as interesting non-organ specific autoantibodies, would become lost in a 'sea of over-interpreted and over-reported laboratory and clinical findings'. It is our contention that 25 years later, this prediction has come to pass, particularly with respect to one type of aPL and its relation to a clinical event, namely anticardiolipin antibodies and early recurrent pregnancy loss. In this commentary, we trace the evolution of the current dogma and propose that reevaluation of available data from an alternative perspective results in quite a different understanding, the acceptance of which would necessitate not only a revision of the classification criteria for APS but also the subsequent revision of many diagnoses.</description><identifier>ISSN: 1355-4786</identifier><identifier>EISSN: 1460-2369</identifier><identifier>DOI: 10.1093/humupd/dms020</identifier><identifier>PMID: 22699010</identifier><language>eng</language><publisher>England</publisher><subject>Antibodies, Anticardiolipin - blood ; Antibodies, Anticardiolipin - immunology ; Antiphospholipid Syndrome - blood ; Antiphospholipid Syndrome - classification ; Antiphospholipid Syndrome - diagnosis ; Embryo Loss - blood ; Embryo Loss - immunology ; Female ; Humans ; Pregnancy ; Recurrence</subject><ispartof>Human reproduction update, 2012-09, Vol.18 (5), p.474-484</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-5968dc6f918819abf7174611631042f8a696aac905b022692b0e63f7c272807e3</citedby><cites>FETCH-LOGICAL-c332t-5968dc6f918819abf7174611631042f8a696aac905b022692b0e63f7c272807e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22699010$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Clark, Christine A</creatorcontrib><creatorcontrib>Laskin, Carl A</creatorcontrib><creatorcontrib>Spitzer, Karen A</creatorcontrib><title>Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence</title><title>Human reproduction update</title><addtitle>Hum Reprod Update</addtitle><description>In 1987, Nigel Harris cautioned against over-diagnosing the antiphospholipid syndrome (APS). In what was a rather prophetic editorial titled 'The Syndrome of the Black Swan', he suggested that while patients with APS do indeed exist, they are probably much more unusual than many medical professionals might like to believe. He expressed concern that the value of studying antiphospholipid antibodies (aPLs) as interesting non-organ specific autoantibodies, would become lost in a 'sea of over-interpreted and over-reported laboratory and clinical findings'. It is our contention that 25 years later, this prediction has come to pass, particularly with respect to one type of aPL and its relation to a clinical event, namely anticardiolipin antibodies and early recurrent pregnancy loss. In this commentary, we trace the evolution of the current dogma and propose that reevaluation of available data from an alternative perspective results in quite a different understanding, the acceptance of which would necessitate not only a revision of the classification criteria for APS but also the subsequent revision of many diagnoses.</description><subject>Antibodies, Anticardiolipin - blood</subject><subject>Antibodies, Anticardiolipin - immunology</subject><subject>Antiphospholipid Syndrome - blood</subject><subject>Antiphospholipid Syndrome - classification</subject><subject>Antiphospholipid Syndrome - diagnosis</subject><subject>Embryo Loss - blood</subject><subject>Embryo Loss - immunology</subject><subject>Female</subject><subject>Humans</subject><subject>Pregnancy</subject><subject>Recurrence</subject><issn>1355-4786</issn><issn>1460-2369</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kE1PwzAMhiMEYjA4ckU5cilzkjZtuE0TX9IkLnClSlMXgvq1pJ3Uf0-mDk5-LT-y7IeQGwb3DJRYfY_N2JersvHA4YRcsFhCxIVUpyGLJIniNJMLcun9DwCTLEvPyYJzqRQwuCCf63awRrvSdrXtbUt16IuutOhDLKlDMzqH7UBRu3qivcOvVrdmonXn_QPV1ITh6CbaVRR3o913RtcU97bE1uAVOat07fH6WJfk4-nxffMSbd-eXzfrbWSE4EOUKJmVRlaKZRlTuqhSlsaSMSkYxLzKtFRSa6MgKeBwOy8ApahSw1OeQYpiSe7mvb3rdiP6IW-sN1jXusVu9DkDASJWADKg0YwaFz5wWOW9s412U4Dyg9J8VprPSgN_e1w9Fg2W__SfQ_ELcDd0Zg</recordid><startdate>201209</startdate><enddate>201209</enddate><creator>Clark, Christine A</creator><creator>Laskin, Carl A</creator><creator>Spitzer, Karen A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201209</creationdate><title>Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence</title><author>Clark, Christine A ; Laskin, Carl A ; Spitzer, Karen A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-5968dc6f918819abf7174611631042f8a696aac905b022692b0e63f7c272807e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Antibodies, Anticardiolipin - blood</topic><topic>Antibodies, Anticardiolipin - immunology</topic><topic>Antiphospholipid Syndrome - blood</topic><topic>Antiphospholipid Syndrome - classification</topic><topic>Antiphospholipid Syndrome - diagnosis</topic><topic>Embryo Loss - blood</topic><topic>Embryo Loss - immunology</topic><topic>Female</topic><topic>Humans</topic><topic>Pregnancy</topic><topic>Recurrence</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Clark, Christine A</creatorcontrib><creatorcontrib>Laskin, Carl A</creatorcontrib><creatorcontrib>Spitzer, Karen A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Human reproduction update</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Clark, Christine A</au><au>Laskin, Carl A</au><au>Spitzer, Karen A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence</atitle><jtitle>Human reproduction update</jtitle><addtitle>Hum Reprod Update</addtitle><date>2012-09</date><risdate>2012</risdate><volume>18</volume><issue>5</issue><spage>474</spage><epage>484</epage><pages>474-484</pages><issn>1355-4786</issn><eissn>1460-2369</eissn><abstract>In 1987, Nigel Harris cautioned against over-diagnosing the antiphospholipid syndrome (APS). In what was a rather prophetic editorial titled 'The Syndrome of the Black Swan', he suggested that while patients with APS do indeed exist, they are probably much more unusual than many medical professionals might like to believe. He expressed concern that the value of studying antiphospholipid antibodies (aPLs) as interesting non-organ specific autoantibodies, would become lost in a 'sea of over-interpreted and over-reported laboratory and clinical findings'. It is our contention that 25 years later, this prediction has come to pass, particularly with respect to one type of aPL and its relation to a clinical event, namely anticardiolipin antibodies and early recurrent pregnancy loss. In this commentary, we trace the evolution of the current dogma and propose that reevaluation of available data from an alternative perspective results in quite a different understanding, the acceptance of which would necessitate not only a revision of the classification criteria for APS but also the subsequent revision of many diagnoses.</abstract><cop>England</cop><pmid>22699010</pmid><doi>10.1093/humupd/dms020</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1355-4786
ispartof Human reproduction update, 2012-09, Vol.18 (5), p.474-484
issn 1355-4786
1460-2369
language eng
recordid cdi_proquest_miscellaneous_1030349006
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Antibodies, Anticardiolipin - blood
Antibodies, Anticardiolipin - immunology
Antiphospholipid Syndrome - blood
Antiphospholipid Syndrome - classification
Antiphospholipid Syndrome - diagnosis
Embryo Loss - blood
Embryo Loss - immunology
Female
Humans
Pregnancy
Recurrence
title Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T03%3A21%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anticardiolipin%20antibodies%20and%20recurrent%20early%20pregnancy%20loss:%20a%20century%20of%20equivocal%20evidence&rft.jtitle=Human%20reproduction%20update&rft.au=Clark,%20Christine%20A&rft.date=2012-09&rft.volume=18&rft.issue=5&rft.spage=474&rft.epage=484&rft.pages=474-484&rft.issn=1355-4786&rft.eissn=1460-2369&rft_id=info:doi/10.1093/humupd/dms020&rft_dat=%3Cproquest_cross%3E1030349006%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1030349006&rft_id=info:pmid/22699010&rfr_iscdi=true